ResearcherRutgers, The State University of New JerseyActive in the last 2 years

Shane S. Neibart

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1294-6082; OpenAlex author ID A5056241109. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer. Co-author DOI 10.2147/ceg.s341189 ↗
Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rationale and Target Delineation for (Neo)Adjuva… First author DOI 10.1016/j.prro.2022.06.004 ↗
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using cap… Co-author DOI 10.21037/jgo-21-503 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Krishan R. Jethwa · 2 shared papers, 2022–2024 · strength 0.56
- Paper Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer. DOI 10.2147/ceg.s341189 ↗
- Paper Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rational… DOI 10.1016/j.prro.2022.06.004 ↗
Shalini Moningi · 1 shared paper, 2024 · strength 0.36
- Paper Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer. DOI 10.2147/ceg.s341189 ↗
Salma K. Jabbour · 2 shared papers, 2021–2022 · strength 0.31
- Paper Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rational… DOI 10.1016/j.prro.2022.06.004 ↗
- Paper Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three… DOI 10.21037/jgo-21-503 ↗
Christopher Leigh Hallemeier · 1 shared paper, 2022 · strength 0.20
- Paper Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rational… DOI 10.1016/j.prro.2022.06.004 ↗
Mark Joseph Truty · 1 shared paper, 2022 · strength 0.20
- Paper Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rational… DOI 10.1016/j.prro.2022.06.004 ↗
H. Richard Alexander · 1 shared paper, 2021 · strength 0.11
- Paper Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three… DOI 10.21037/jgo-21-503 ↗
Lyudmyla Derby Berim · 1 shared paper, 2021 · strength 0.11
- Paper Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three… DOI 10.21037/jgo-21-503 ↗
Prateek Gulhati · 1 shared paper, 2021 · strength 0.11
- Paper Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three… DOI 10.21037/jgo-21-503 ↗
Howard S. Höchster · 1 shared paper, 2021 · strength 0.11
- Paper Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three… DOI 10.21037/jgo-21-503 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.